April 1, 1998

Incidence and Clinical Significance of False-Negative Sextant Prostate Biopsies

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Our findings suggest that this 23% incidence of false-negative biopsies represents significant cancer. This relatively high incidence is important to consider in treatment modalities in which prostate biopsy may be performed to determine response to therapy.

Me gusta

Guardar

Cite This Study

Rabbani et al. (Wed,) studied this question.

synapsesocial.com/papers/69de828a741e97d2d4e93c96 https://doi.org/https://doi.org/10.1016/s0022-5347(01)63574-2

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical significance of repeat sextant biopsies in prostate cancer patients1997 · 111 citations
2Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study1997 · 39 citations
3Indications for transition zone biopsy in the detection of prostatic carcinoma.1997 · 95 citations
4Palpable masses in the prostate: superior accuracy of US-guided biopsy compared with accuracy of digitally guided biopsy.1991 · 46 citations
5Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate.1993 · 24 citations

Me gusta

Guardar